BBLGW Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 jun 2024 @ 22:00):
Our systems believe the stock currently is undervalued by 0.03% compare to its pairs and should correct upwards.

Stats
Dagens volum	14
Gjennomsnittsvolum	679
Markedsverdi	1.74M
EPS	$-1.310 ( Q1 \| 2024-05-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-302.08 (Sector) 42.63 (Industry) 43.86
ATR14	$0 (0.00%)

ABMD 0.00%

AMIX -2.65%

BBLGW -19.30%

BVS 1.46%

COCH 0.43%

DHAI -4.85%

DHAIW 0.00%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -2.26%

HSCSW 19.64%

IINNW -27.42%

INVO -6.67%

LFWD 0.49%

MDAI 1.82%

MGRM -2.86%

MXCT -2.57%

NVNOW -32.98%

NXL 24.78%

NXLIW -25.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ -4.76%

PETVW 0.00%

QTI 1.57%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-01-17	Walsh Deina H	Buy	12 500	Employee Stock Option
2024-01-17	Frelick Jeff	Buy	25 000	Employee Stock Option
2024-01-08	Gagnon Robert E.	Buy	8	Non-Employee Stock Option
2024-01-08	Gagnon Robert E.	Buy	9	Non-Employee Stock Option
2024-01-08	Gagnon Robert E.	Sell	0	Common Stock

INSIDER POWER
33.97
Last 92 transactions
Buy: 61 917 793 \| Sell: 15 856 455

Korrelasjon (AI algo v.1.1b): Undervalued: 0.03% $43.51 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Bone Biologics Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Bone Biologics Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-34.01

FY	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-34.01

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$14.62

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Bone Biologics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Bone Biologics

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.